ADM Tronics Launches Major Expansion of Medical Device Design and Engineering Capabilities

NORTHVALE, N.J. – Feb. 8, 2017 – ADM Tronics Unlimited, Inc. (ADMT) has announced today that due to greatly increased customer projects and orders, the Company has launched a major expansion of its medical device design, engineering and manufacturing capabilities.  The acquisition and installation of state-of-the-art capital equipment promises to speed the development of medical device prototypes and enable automated precision manufacturing of components to increase dramatically, which in turn, converts into the opportunity for significant growth in revenues.

“We are excited about bringing this automated production machinery into our engineering infrastructure,” stated Andre’ DiMino, CEO of ADMT.  “And, we are proud to be contributing to the renewed goal of bringing quality manufacturing back to America, especially doing this with equipment also made in America.”  Mr. DiMino is referring to the two manufacturers of the equipment, Haas Automation, Inc., one of the largest machine tool builders in the world, manufacturing its equipment in California, and Shopsabre CNC of Minnesota, manufacturers of automated plasma metal cutters.

The addition of the automated CNC machine tool equipment further distinguishes ADMT from its competition.  Timothy Gilmartin, Vice President Production, stated, “In my over three decades with ADMT this is the most dramatic expansion of equipment and capacity we have installed.  This is now propelling ADMT to the status of being the company of choice for engineering and developing the most advanced electronic medical device technologies.”  Mr. Gilmartin continued, “We now have equipment that can give us an end-to-end pipeline for bringing our customers’ products, as well as our own proprietary products, from the conceptual stage right into automated manufacturing, all in-house.” 

“We believe this investment has the potential to bring us a dramatic return on investment that will only grow over time,” concluded Mr. DiMino.

ADMT specializes in electronic medical device design, development and manufacturing for diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ.  The Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to medical devices.  Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms which supply only portions of those services.

In addition to engineering, regulatory and manufacturing services for both partners and clients, ADMT has a number of proprietary medical devices.  These devices, conceived, designed and produced in-house include therapeutic and diagnostic medical technologies in fields as diverse as audiology, physical medicine, wound therapy, neurology and urology.

Additional information is available at the Company’s website – as well as

About ADMT

ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products.  Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house.  ADMT has three Business Segments: Proprietary Electronic Medical Devices; Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Safe, Water-Based Formulations.  The Company’s headquarters, laboratories, medical device and manufacturing operations are located in Northvale, New Jersey.  ADMT’s multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D solid prototyping, precision instrumentation and specialized software and peripherals for the research, development and commercialization of diversified technologies.

Except for historical information contained herein, the matters set forth in this news release are “forward looking” statements (as defined in the Private Securities Litigation Reform Act of 1995).  Although ADMT believes the expectations reflected in such forward looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations.  Factors that could contribute to such differences include those described from time to time in ADMT’s filings with the SEC, news releases and other communications.

Distributed by Microcap Headlines, Inc.

Media Contact
Company Name: Microcap Headlines, Inc.
Contact Person: Natalie Peccia
Phone: (877) 283-6422
Country: United States